Assessing both genetic variation (SNPs/CNVs) and gene–environment interactions may lead to personalized gastric cancer prevention

References

• Frazer KA, Ballinger DG, Cox DR et al.; International HapMap Consortium. A second generation human haplotype map of over 3.1 million SNPs. Nature449(7164), 851–861 (2007).
   PubMed Web of Science ®Google Scholar
• Manolio TA, Brooks LD, Collins FS. A HapMap harvest of insights into the genetics of common disease. J. Clin. Invest.118, 1590–1605 (2008).
   PubMed Web of Science ®Google Scholar
• Birney E, Stamatoyannopoulos JA, Dutta A et al.; ENCODE Project Consortium. Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature447(7146), 799–816 (2007).
   PubMed Web of Science ®Google Scholar
• [No authors listed]. My genome. So, what. Nature456(7218), 1 (2008).
   Google Scholar
• Ley TJ, Mardis ER, Ding L et al. DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome. Nature456(7218), 66–72 (2008).
   PubMed Web of Science ®Google Scholar
• Pennisi E. Breakthrough of the year. Human genetic variation. Science318(5858), 1842–1843 (2007).
   PubMed Web of Science ®Google Scholar
• Roukos DH. Innovative genomic-based model for personalized treatment of gastric cancer: integrating current standards and new technologies. Expert Rev. Mol. Diagn.8(1), 29–39 (2008).
   PubMed Web of Science ®Google Scholar
• Vineis P, Brennan P, Canzian F et al. Expectations and challenges stemming from genome-wide association studies. Mutagenesis23(6), 439–444 (2008).
   Google Scholar
• Chanock SJ, Manolio T, Boehnke M et al. Replicating genotype-phenotype associations. Nature447(7145), 655–660 (2007).
   PubMed Web of Science ®Google Scholar
• Roukos DH, Lykoudis E, Liakakos T. Genomics and challenges toward personalized breast cancer local control. J. Clin. Oncol.10, 26(26), 4360–4361 (2008).
   Google Scholar
• Roukos DH. Personal genomics and genome-wide association studies: novel discoveries but limitations for practical personalized medicine. Ann. Surg. Oncol. (2008) (Epub ahead of print) DOI: 10.1245/s10434–008–0109–0106.
   Google Scholar
• Lee C, Morton CC. Structural genomic variation and personalized medicine. N. Engl. J. Med.358(7), 740–741 (2008).
   PubMedGoogle Scholar
• Lupski JR. Structural variation in the human genome. N. Engl. J. Med.356(11), 1169–1171 (2007).
   PubMed Web of Science ®Google Scholar
• Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence, mortality, and revalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J. Clin. Oncol.24(14), 2137–2150 (2006).
   PubMed Web of Science ®Google Scholar
• Sasako M, Sano T, Yamamoto S et al. for Japan Clinical Oncology Group. D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer. N. Engl. J. Med.359(5), 453–462 (2008).
   PubMed Web of Science ®Google Scholar
• Forman D, Pisani P. Gastric cancer in Japan – honing treatment, seeking causes. N. Engl. J. Med.359(5), 448–451 (2008).
   PubMedGoogle Scholar
• Lichtenstein P, Holm NV, Verkasalo PK et al. Environmental and heritable factors in the causation of cancer – analyses of cohorts of twins from Sweden, Denmark, and Finland. N. Engl. J. Med.343(2), 78–85 (2000).
   PubMed Web of Science ®Google Scholar
• Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. Acta Pathol. Microbiol. Scand.64, 31–49 (1965).
   PubMedGoogle Scholar
• Sakamoto H, Yoshimura K, Saeki N et al.; Study Group of Millennium Genome Project for Cancer. Genetic variation in PSCA is associated with susceptibility to diffuse-type gastric cancer. Nat. Genet.40(6), 730–740 (2008).
   PubMed Web of Science ®Google Scholar
• Roukos DH. Current status and future perspectives in gastric cancer management. Cancer Treat. Rev.26(4), 243–255 (2000).
   PubMedGoogle Scholar
• Guilford P, Hopkins J, Harraway J et al. E-cadherin germline mutations in familial gastric cancer. Nature392(6674), 402–405 (1998).
   PubMed Web of Science ®Google Scholar
• Pharoah PD, Guilford P, Caldas C; International Gastric Cancer Linkage Consortium. Incidence of gastric cancer and breast cancer in CDH1 (E-cadherin) mutation carriers from hereditary diffuse gastric cancer families. Gastroenterology121(6), 1348–1353 (2001).
   PubMed Web of Science ®Google Scholar
• Brooks-Wilson AR et al. Germline E-cadherin mutations in hereditary diffuse gastric cancer: assessment of 42 new families and review of genetic screening criteria. J. Med. Genet.41, 508–517 (2004).
   PubMed Web of Science ®Google Scholar
• Barber M, Fitzgerald RC, Caldas C. Familial gastric cancer – aetiology and pathogenesis. Best Pract. Res. Clin. Gastroenterol.20(4), 721–734 (2006).
   PubMed Web of Science ®Google Scholar
• Norton JA, Ham CM, Van Dam J et al.CDH1 truncating mutations in the E-cadherin gene: an indication for total gastrectomy to treat hereditary diffuse gastric cancer. Ann. Surg.245, 873–879 (2007).
   PubMed Web of Science ®Google Scholar
• Ziogas D, Baltogiannis G, Fatouros M, Roukos DH. Identifying and preventing high-risk gastric cancer individuals with CDH1 mutations. Ann. Surg.247(4), 714–715 (2008).
   PubMedGoogle Scholar
• Taylor PR. Prevention of gastric cancer: a miss. J. Natl Cancer Inst.99(2), 101–103 (2007).
   PubMedGoogle Scholar
• Easton DF, Pooley KA, Dunning AM et al. Genome-wide association study identifies novel breast cancer susceptibility loci. Nature447(7148), 1087–1093 (2007).
   PubMed Web of Science ®Google Scholar
• Zheng SL, Sun J, Wiklund F et al. Cumulative association of five genetic variants with prostate cancer. N. Engl. J. Med.358(9), 910–909 (2008).
   PubMed Web of Science ®Google Scholar
• Hunter DJ, Khoury MJ, Drazen JM. Letting the genome out of the bottle – will we get our wish? N. Engl. J. Med.358(2), 105–107 (2008).
   PubMed Web of Science ®Google Scholar
• Pharoah PD, Antoniou A, Bobrow M, Zimmern RL, Easton DF, Ponder BA. Polygenic susceptibility to breast cancer and implications for prevention. Nat. Genet.31(1), 33–36 (2002).
   PubMed Web of Science ®Google Scholar
• Liu C, Russell RM. Nutrition and gastric cancer risk: an update. Nutr. Rev.66(5), 237–249 (2008).
   PubMed Web of Science ®Google Scholar
• Mossé YP, Laudenslager M, Longo L et al. Identification of ALK as a major familial neuroblastoma predisposition gene. Nature455(7215), 930–935 (2008).
   PubMed Web of Science ®Google Scholar
• Paik S, Shak S, Tang G et al. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N. Engl. J. Med.351, 2817–2826 (2004).
   PubMed Web of Science ®Google Scholar
• Roukos DH. 21-gene assay: challenges and promises in translating personal genomics and whole genome scans into personalized treatment of breast cancer. J. Clin. Oncol. (In press).
   Google Scholar
• Esteller M. Epigenetics in cancer. N. Engl. J. Med.358, 1148–1159 (2008).
   PubMed Web of Science ®Google Scholar